Survival

Adding Tumor Lysate-Loaded Autologous Dendritic Cell Vaccination to Standard of Care Associated with Clinically Improved Overall Survival in Patients With Newly Diagnosed and Recurrent Glioblastoma |  Medicine in 2 Minutes

Adding Tumor Lysate-Loaded Autologous Dendritic Cell Vaccination to Standard of Care Associated with Clinically Improved Overall Survival in Patients With Newly Diagnosed and Recurrent Glioblastoma | Medicine in 2 Minutes

1. In this phase 3 non-randomized controlled trial, among 331 patients, patients with newly diagnosed glioblastoma (nGBM) receiving dendritic cell vaccination (DCVax-L) had a median overall survival of 19.3 months versus 16.5 months in outpatient control patients treated with standard of care. 2. Patients with recurrent glioblastoma (rGBM) had a median overall survival of 13.2 …

Adding Tumor Lysate-Loaded Autologous Dendritic Cell Vaccination to Standard of Care Associated with Clinically Improved Overall Survival in Patients With Newly Diagnosed and Recurrent Glioblastoma | Medicine in 2 Minutes Read More »

Lung Cancer Survival Rates: 5 Myths Everyone Needs to Stop Believing

Lung Cancer Survival Rates: 5 Myths Everyone Needs to Stop Believing

Stay ahead of the fashion trend and beyond with our free weekly Lifestyle Edit newsletter Stay ahead of the fashion trend and beyond with our free weekly Lifestyle Edit newsletter TV presenter Jonnie Irwin has revealed he has terminal cancer, which started in his lungs and has now spread to his brain. The Channel 4 …

Lung Cancer Survival Rates: 5 Myths Everyone Needs to Stop Believing Read More »